Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ouellet

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Clinical Pharmacology and Therapeutics|November 3, 1998
Pharmacokinetic interaction between ritonavir and clarithromycinD Ouellet, A Hsu, G R Granneman, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1998
Effect of fluoxetine on pharmacokinetics of ritonavirD Ouellet, A Hsu, J Qian, et al.
British Journal of Clinical Pharmacology|September 2, 1998
Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteersD Ouellet, A Hsu, J Qian, et al.
Journal of Hazardous Materials|October 20, 2018
Marine microplastics bound dioxin-like chemicals: Model explanation and risk assessmentQiqing Chen, Haibo Zhang, Annika Allgeier, et al.
Journal of Clinical Pharmacology|May 22, 2001
Single-dose gabapentin pharmacokinetics and safety in healthy infants and childrenG M Haig, H N Bockbrader, D L Wesche, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunitiesK Venkatakrishnan, L E Friberg, D Ouellet, et al.
Journal of Hazardous Materials|July 27, 2021
Remobilization of pollutants during extreme flood events poses severe risks to human and environmental healthSarah E Crawford, Markus Brinkmann, Jacob D Ouellet, et al.
The Science of the Total Environment|June 15, 2018
Looking back - Looking forward: A novel multi-time slice weight-of-evidence approach for defining reference conditions to assess the impact of human activities on lake systemsHenner Hollert, Sarah E Crawford, Werner Brack, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2014
Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trialA M Menzies, M T Ashworth, S Swann, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Clinical Pharmacology and Therapeutics|November 3, 1998
Pharmacokinetic interaction between ritonavir and clarithromycinD Ouellet, A Hsu, G R Granneman, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1998
Effect of fluoxetine on pharmacokinetics of ritonavirD Ouellet, A Hsu, J Qian, et al.
British Journal of Clinical Pharmacology|September 2, 1998
Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteersD Ouellet, A Hsu, J Qian, et al.
Journal of Hazardous Materials|October 20, 2018
Marine microplastics bound dioxin-like chemicals: Model explanation and risk assessmentQiqing Chen, Haibo Zhang, Annika Allgeier, et al.
Journal of Clinical Pharmacology|May 22, 2001
Single-dose gabapentin pharmacokinetics and safety in healthy infants and childrenG M Haig, H N Bockbrader, D L Wesche, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunitiesK Venkatakrishnan, L E Friberg, D Ouellet, et al.
Journal of Hazardous Materials|July 27, 2021
Remobilization of pollutants during extreme flood events poses severe risks to human and environmental healthSarah E Crawford, Markus Brinkmann, Jacob D Ouellet, et al.
The Science of the Total Environment|June 15, 2018
Looking back - Looking forward: A novel multi-time slice weight-of-evidence approach for defining reference conditions to assess the impact of human activities on lake systemsHenner Hollert, Sarah E Crawford, Werner Brack, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2014
Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trialA M Menzies, M T Ashworth, S Swann, et al.
Pageof 4